News & Events

Research team of QDST’s poster presentation in ECCMID 2019

2019.04.14.

[Research team of QDST's poster presentation in ECCMID 2019]

The tuberculosis research and development department of QuantaMatrix gave a poster presentation on QDST, an anti-tuberculosis drug susceptibility test system, in the 29th The European Society of Clinical Microbiology and Infectious Disease (ECCMID). The team delivered outcomes from a joint research between QuantaMatrix and the Asan Medical Center under the title of `Clinical evaluation of QMAC DST system with MDR-TB and XDR-TB against first- and second-line drugs’ for about an hour from 1:30 PM on April 14. We express our genuine gratitude towards the delegates who attended the presentation session.

The original text of the poster presentation is archived in eLibrary. (https://www.escmid.org/escmid_publications/escmid_elibrary/)

List
CARB-X awards $2.85 million to QuantaMatrix’s neonatal sepsis diagnostic platform
QuantaMatrix unveils world’s fastest antimicrobial testing technology backed by research paper in Nature
Awarded winner of Sepsis tender from the Great Orchestra of Christmas Charity – WOŚP in Poland!
dRAST solution receives European CE Marking IVDR
QuantaMatrix signed new distribution partnership with Neo-Science for the UAE market